Aegis Capital invests in Approxima; DZP advises the fund on participation in EUR 8.8 million funding round

Aegis Capital, a venture capital fund investing in healthcare projects, joined a funding round conducted by the Italian-Polish startup Approxima, which raised a total of EUR 8.8 million. The company is developing a novel solution for use in cardiac surgery, addressing essential clinical needs in the treatment of valvular heart disease.

The investment marks the first step in building up the fund's portfolio and will enable it to engage in a project with global commercial potential.

Experts from the Capital Markets and Financial Institutions Practice were responsible for preparing the transaction documentation and supported the client in negotiations and with legal advice throughout the process.

The work was carried out by Katarzyna Wójcik (Associate) and the transaction was supervised by Maciej Zajda (Partner).